“…More than 25 years of experience has accumulated since the advent of cysticidals [12], and along this time countless studies have been performed with albendazole and with praziquantel and have provided answers to these three main questions: 1) adverse inflammatory reactions secondary to the drug-induced destruction of parasites are effectively controlled by a brief course of steroid therapy; 2) long-term studies have shown that the opportune elimination of parasites is frequently accompanied by improvement of the specific neurologic dysfunctions caused by the parasites [1, 29,32,33]; and, more important, 3) it seems logical to consider that in NCC, as in any other infectious disease in which an effective and convenient therapy exists (in economical cost, drug toxicity, and length of therapy), there is no reason to leave the disease to follow its natural course, in patients with mild forms of the disease, when an effective and safe cure can be achieved [6••, 34]. Currently, most experts agree with the use of antihelmintic therapy when viable cysticerci are encountered [6••, 33].…”